Page last updated: 2024-11-06

mitomycin and Cryptogenic Fibrosing Alveolitis

mitomycin has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Luis-García, ER1
Becerril, C1
Salgado-Aguayo, A1
Aparicio-Trejo, OE1
Romero, Y1
Flores-Soto, E1
Mendoza-Milla, C1
Montaño, M1
Chagoya, V1
Pedraza-Chaverri, J1
El Hafidi, M1
Orozco-Ibarra, M1
Pardo, A1
Selman, M1

Other Studies

1 other study available for mitomycin and Cryptogenic Fibrosing Alveolitis

ArticleYear
Mitochondrial Dysfunction and Alterations in Mitochondrial Permeability Transition Pore (mPTP) Contribute to Apoptosis Resistance in Idiopathic Pulmonary Fibrosis Fibroblasts.
    International journal of molecular sciences, 2021, Jul-23, Volume: 22, Issue:15

    Topics: Adenosine Triphosphate; Apoptosis; Calcium; Cytochromes c; Fibroblasts; Humans; Idiopathic Pulmonary

2021